Longevium raises $7 million for a Dubai laboratory supporting its biological age platform

Longevium raises $7 million for a Dubai laboratory supporting its biological age platform

On August 4, the Longevium clinic network announced its first $7 million investment round. The company has begun building the Longevity AI Research Laboratory at Dubai Science Park and plans to open the center in Q4 2026.

Longevium already operates three clinics in Dubai. The new funding will support a laboratory and research team that the company is establishing separately from its clinical network. Longevium is adding its own research facility to its patient care operations. The clinics will provide examination data for the program, while the laboratory will combine these data into a unified model. This structure allows the company’s clinicians and researchers to work with the same measurements.

In its press release, the company describes a biological age platform intended to combine laboratory biomarkers, ultrasound imaging, body composition measurements, and wearable device data into a single estimate. These measurements reflect different aspects of a person’s condition. Longevium intends to use this dataset to produce an estimate of biological age.

The independent publication EnterpriseAM confirms the investment amount, location, and planned opening date. Longevium plans to open the laboratory at Dubai Science Park in Q4 2026, where it will bring clinical measurements together within its own research program.